Prognostic Significance of Reduction in Ki67 Index After Neoadjuvant Chemotherapy in Patients With Breast Cancer in Kerman Between 2009 And 2014

BACKGROUND AND OBJECTIVE: Breast cancer is the most common malignancy among women. The Neoadjuvant chemotherapy is the treatment of choice for non-operable tumors. The Ki67 is a proliferation marker that can be used to predict the therapeutic response to chemotherapy and the patients' prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Moazed, Vahid, Jafari, Elham, Kalantari Khandani, Behjat, Nemati, Ali, Roozdar, Alale, Ben Razavi, Seyyed Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Society of Pathology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929391/
https://www.ncbi.nlm.nih.gov/pubmed/29731798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929391/
https://www.ncbi.nlm.nih.gov/pubmed/29731798

Ejemplares similares